326 related articles for article (PubMed ID: 9930159)
1. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
[TBL] [Abstract][Full Text] [Related]
2. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
3. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis.
Glueck CJ; Fontaine RN; Gruppo R; Stroop D; Sieve-Smith L; Tracy T; Wang P
Clin Orthop Relat Res; 1999 Sep; (366):133-46. PubMed ID: 10627727
[TBL] [Abstract][Full Text] [Related]
4. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
[TBL] [Abstract][Full Text] [Related]
5. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion.
Glueck CJ; Wang P; Bell H; Rangaraj V; Goldenberg N
Clin Appl Thromb Hemost; 2005 Oct; 11(4):375-89. PubMed ID: 16244763
[TBL] [Abstract][Full Text] [Related]
6. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men.
Glueck CJ; Goldenberg N; Golnik K; Sieve L; Wang P
Clin Appl Thromb Hemost; 2005 Oct; 11(4):441-8. PubMed ID: 16244770
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
9. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke.
Glueck CJ; Fontaine RN; Wang P
Thromb Haemost; 2001 Feb; 85(2):256-9. PubMed ID: 11246543
[TBL] [Abstract][Full Text] [Related]
10. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
11. Amaurosis fugax: associations with heritable thrombophilia.
Glueck CJ; Goldenberg N; Bell H; Golnik K; Wang P
Clin Appl Thromb Hemost; 2005 Jul; 11(3):235-41. PubMed ID: 16015408
[TBL] [Abstract][Full Text] [Related]
12. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
Nowak-Göttl U; Sträter R; Kosch A; von Eckardstein A; Schobess R; Luigs P; Nabel P; Vielhaber H; Kurnik K; Junker R
Eur J Haematol; 2001 Jan; 66(1):57-62. PubMed ID: 11168509
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
14. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
Jusić A; Balić D; Avdić A; Pođanin M; Balić A
Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
16. CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS: Association With Multigenetic Variants of Thrombophilia.
Bremond-Gignac D; Daruich A; Gallet M; Menoud PA; Nowomiejska K; Rejdak R; Behar-Cohen F; Benkhalifa M; Copin H
Retina; 2020 Jul; 40(7):1339-1343. PubMed ID: 31095065
[TBL] [Abstract][Full Text] [Related]
17. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.
Glueck CJ; Pranikoff J; Aregawi D; Haque M; Zhu B; Tracy T; Wang P
Metabolism; 2005 Oct; 54(10):1345-9. PubMed ID: 16154434
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss.
Glueck CJ; Wang P; Bornovali S; Goldenberg N; Sieve L
Metabolism; 2003 Dec; 52(12):1627-32. PubMed ID: 14669168
[TBL] [Abstract][Full Text] [Related]
19. Hypofibrinolysis, thrombophilia, osteonecrosis.
Glueck CJ; Freiberg RA; Fontaine RN; Tracy T; Wang P
Clin Orthop Relat Res; 2001 May; (386):19-33. PubMed ID: 11347834
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland.
Gagala J; Buraczynska M; Mazurkiewicz T; Ksiazek A
BMC Musculoskelet Disord; 2013 Sep; 14():264. PubMed ID: 24025446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
